(Q28743383)

English

A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days

scientific article (publication date: 20 January 2011)

Statements

A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days (English)
0 references
0 references
0 references
0 references
0 references
Joelle Brown
0 references
Anna-Barbara Moscicki
0 references
Jeremy R A Paull
0 references
Clare F Price
0 references
Stephen Shiboski
0 references
20 January 2011
0 references
0 references
6
0 references
1
0 references
e16258
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit